Clinical Trial Update: Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer

View source ↗

Summary

An NCI-sponsored trial characterizes individuals and families at high risk of hematologic cancers, focusing on conditions including Waldenström macroglobulinemi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Hodgkin Lymphoma
• Mixed Lymphoproliferative Disease
• Non-hodgkin Lymphoma
• Waldenström Macroglobulinemia

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Waldenstrom Macroglobulinemia, Chronic Lymphocytic Leukemia | Status: ACTIVE_NOT_RECRUITING